Searchable abstracts of presentations at key conferences in endocrinology

ea0050ep085 | Neuroendocrinology and Pituitary | SFEBES2017

Severe hypoglycaemia in a woman with secondary hypoadrenalism and an abnormal pituitary stalk, complicating metastatic breast carcinoma

Kamath Chandan , Premawardhana Lakdasa , Adlan Mohammed

Introduction: Significant hypoglycaemia is a rare but well recognised presenting feature of secondary adrenal insufficiency. Such hypoadrenalism may be caused by intrinsic hypothalamo-pituitary disease (pituitary adenoma), exogenous steroid therapy, and uncommonly by hypophysitis and pituitary secondaries from malignant disease.Case presentation: A 73-year-old woman presented acutely with confusion, agitation, and a...

ea0050ep085 | Neuroendocrinology and Pituitary | SFEBES2017

Severe hypoglycaemia in a woman with secondary hypoadrenalism and an abnormal pituitary stalk, complicating metastatic breast carcinoma

Kamath Chandan , Premawardhana Lakdasa , Adlan Mohammed

Introduction: Significant hypoglycaemia is a rare but well recognised presenting feature of secondary adrenal insufficiency. Such hypoadrenalism may be caused by intrinsic hypothalamo-pituitary disease (pituitary adenoma), exogenous steroid therapy, and uncommonly by hypophysitis and pituitary secondaries from malignant disease.Case presentation: A 73-year-old woman presented acutely with confusion, agitation, and a...

ea0050ep098 | Reproduction | SFEBES2017

Siginificant hyperandrogenism in a postmenopausal woman from a likely ovarian source

Kamath Chandan , Routledge M , Ashraf M , Premawardhana Lakdasa , Adlan Mohammed

Introduction: The polycystic ovary syndrome is the commonest cause for hyperandrogenism in young women. However, in older women, adrenal and ovarian tumours are more common, particularly if (a) hyperandrogenism is of short duration, (b) causes significant clinical androgenisation, and (c) is biochemically severe. We present an elderly woman who presented diagnostic and therapeutic challenges on account of her comorbidities.Case Present...

ea0050ep100 | Thyroid | SFEBES2017

Thymic hyperplasia in Graves’ disease – wait and see, or intervene?

Kamath Chandan , MacAleer B , Adlan Mohammed , Premawardhana Lakdasa

Introduction: There is no consensus about the management of thymic enlargement in Graves’ disease (GD). If imaging indicates ‘benign’ thymic appearances, and interval scans are stable, most authorities advocate no intervention until thyrotoxicosis is controlled. We present 3 patients with GD and incidentally found thymic enlargement.Case presentations: a. A 37-year-old female presented acutely with osmotic symptoms, a weight ...

ea0050ep098 | Reproduction | SFEBES2017

Siginificant hyperandrogenism in a postmenopausal woman from a likely ovarian source

Kamath Chandan , Routledge M , Ashraf M , Premawardhana Lakdasa , Adlan Mohammed

Introduction: The polycystic ovary syndrome is the commonest cause for hyperandrogenism in young women. However, in older women, adrenal and ovarian tumours are more common, particularly if (a) hyperandrogenism is of short duration, (b) causes significant clinical androgenisation, and (c) is biochemically severe. We present an elderly woman who presented diagnostic and therapeutic challenges on account of her comorbidities.Case Present...

ea0050ep100 | Thyroid | SFEBES2017

Thymic hyperplasia in Graves’ disease – wait and see, or intervene?

Kamath Chandan , MacAleer B , Adlan Mohammed , Premawardhana Lakdasa

Introduction: There is no consensus about the management of thymic enlargement in Graves’ disease (GD). If imaging indicates ‘benign’ thymic appearances, and interval scans are stable, most authorities advocate no intervention until thyrotoxicosis is controlled. We present 3 patients with GD and incidentally found thymic enlargement.Case presentations: a. A 37-year-old female presented acutely with osmotic symptoms, a weight ...

ea0028p93 | Clinical practice/governance and case reports | SFEBES2012

Intractable nephrogenic diabetes insipidus, transient thyroiditis and hypercalcaemia complicating long term Lithium therapy

Kamath Chandan , Govindan Jyotish , Premawardhana Amila , Wood Sarah , Adlan Mohamed , Premawardhana Lakdasa

Introduction Lithium (Li) is an effective treatment for bipolar and schizo-affective disorders. It has a narrow therapeutic index, and produces common side effects when this is exceeded. Li causes endocrine disruption by predictable and some hitherto unclear mechanisms. We present a subject who developed multiple Li induced endocrinopathies concurrently, and was a therapeutic challenge. Case presentation and investigations Mr. DM had been on Li for 10 years and developed polyu...